๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-14

ONE-P TMS First Responders (NCT07773935)

One-day rTMS + D-cycloserine to Treat PTSD in First Responders

๐ŸŸก Not Yet Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The aim of this study is to examine the feasibility and tolerability of a one-day protocol of repetitive transcranial magnetic stimulation with D-cycloserine (DCS) as an augmentation strategy in first responders who have PTSD.

Who can join: Review the eligibility criteria below.

Location: Non-Invasive Neurostimulation Therapies Centre, University of British Columbia โ€” Vancouver, British Columbia

Age range: 19 Years to 60 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Non-Invasive Neurostimulation Therapies Centre, University of British Columbia โ€” Vancouver, British Columbia

๐Ÿ“ž Contact the Study Coordinator

Phone: (604) 822-7308

Email: ninet.lab@ubc.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in PTSD - Post Traumatic Stress Disorder

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—